News 01

The group was established in 2013 and has now become an international medical group integrating R&D, manufacturing and sales, with multiple subsidiaries and overseas branches. In the past few years, we have obtained FDA, CE, ISO13485, ISO9001 and other international certifications. In 2020, we achieved sales revenue of more than US$50 million. The existing factory area is approximately 33,000 square meters; a factory covering an area of 68,000 square meters will begin operations in 2022. We focus on product quality and have strict quality control. Products are mainly positioned in high-end medical markets, such as the United States, the United Kingdom, Canada, Western Europe, Australia, etc. We mainly cooperate with major medical groups in North America and Western Europe to develop long-term friendly cooperation.